Stay updated on Nivolumab in Hodgkin's Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Hodgkin's Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Hodgkin's Lymphoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now displays the completed Phase 2 nivolumab study record for classical Hodgkin lymphoma, including its design, eligibility criteria, locations, outcomes, publications, and study documents.
    Difference
    81%
    Check dated 2026-11-08T11:56:12.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page no longer displays the 403 error message, but the study record content is absent and only the site navigation and footer are visible.
    Difference
    0.6%
    Check dated 2026-11-01T12:25:50.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    An NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” across NIH content. It appears above the ClinicalTrials.gov 403 error page.
    Difference
    1%
    Check dated 2026-10-25T12:27:48.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T13:31:56.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The error page’s footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T13:51:26.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with an error screen and basic navigation. This indicates access to the page is blocked or unavailable, with the footer showing a revision note.
    Difference
    20%
    Check dated 2026-09-20T19:55:43.000Z thumbnail image

Stay in the know with updates to Nivolumab in Hodgkin's Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Hodgkin's Lymphoma Clinical Trial page.